Press Releases

2007 | 2006 | 2005 | 2004

10/01/07
Othera Pharmaceuticals Appoints Dr. Frederick R. Rickles as Chief Scientific Officer

6/18/07
Othera Pharmaceuticals and the National Eye Institute Reach Target Enrollment in Dry AMD Clinical Trial with OT-551 Eye Drops

6/11/07
Othera Pharmaceuticals Announces First Patient Dosed with OT-551 Eye Drops in a Phase 2 Clinical Trial of Geographic Atrophy

4/19/07
Othera Pharmaceuticals Announces Upcoming Presentation Based Upon Expanded Understanding of Lead Compound Mechanism of Action

2/26/07
Othera Pharmaceuticals Presents New AMD Data at Angiogenesis 2007 Symposium